Titan Pharmaceuticals (NASDAQ:TTNP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report released on Monday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance TTNP stock opened at $0.33 on Monday. The company has a 50 day moving average price of $0.35 and a […]

Leave a Reply

Your email address will not be published.

Previous post Johnson & Palladino: Savings $$ should be added to alimony in MA
Next post Oncternal Therapeutics (NASDAQ:ONCT) Earns Sell Rating from Analysts at StockNews.com